Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study
Phase of Trial: Phase I
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Rose bengal sodium (Primary)
- Indications Malignant melanoma
- Focus Biomarker; Pharmacodynamics
- 18 Apr 2017 Status changed from active, no longer recruiting to completed.
- 28 Mar 2017 Planned End Date changed from 1 Apr 2017 to 1 Jan 2018.
- 25 Oct 2016 Planned End Date changed from 1 Dec 2016 to 1 Apr 2017.